Litcius/Paper detail

Exosome-mediated aptamer S58 reduces fibrosis in a rat glaucoma filtration surgery model

Qianyi Lin, Yu Leng, Xiaomin Zhu, Min Tang, Yi Lin, Wangdu Luo, Bingcai Jiang, Xia Chen, Lin Xie

2022International Journal of Ophthalmology22 citationsDOIOpen Access PDF

Abstract

AIM: To confirm whether exosome-mediated delivery of aptamer S58 (Exo-S58) has a better antifibrotic effect than naked S58 in human conjunctival fibroblasts (HConFs) and a rat glaucoma filtration surgery (GFS) model. METHODS: To enhance the effective reaction time of aptamer S58 in vivo, we loaded aptamer S58 into exosomes derived from HEK293T cells by PEI transfection to determine the effect of Exo-S58 in HConFs and a rat GFS model. RESULTS: Exo-S58 can significantly reduce cell proliferation, migration and fibrosis in TGF-β2-induced HConFs. In an in vivo experiment, Exo-S58 treatment prolonged filtering bleb retention and reduced fibrosis compared with naked S58 treatment in GFS rats. CONCLUSION: The exosomes are safe and valid carriers to deliver aptamers. Furthermore, Exo-S58 exhibited superior antifibrotic effect than naked S58 both in HConFs cells and rat GFS models.

Topics & Concepts

AptamerExosomeIn vivoMicrovesiclesMedicineFibrosisTransfectionGlaucomaBleb (medicine)Cell biologyCancer researchMolecular biologyPathologyOphthalmologymicroRNABiologyBiochemistryTrabeculectomyGeneBiotechnologyExtracellular vesicles in diseaseCorneal Surgery and TreatmentsVestibular and auditory disorders
Exosome-mediated aptamer S58 reduces fibrosis in a rat glaucoma filtration surgery model | Litcius